Edwards Lifesciences (EW) Change in Taxes (2014 - 2026)

Edwards Lifesciences' Change in Taxes history runs 13 years deep, the most recent figure standing at $41.9 million for Q1 2026.

• On a quarterly basis, Change in Taxes fell 18.16% year-over-year to $41.9 million in Q1 2026; TTM through Mar 2026 was -$151.1 million, a 218.42% decrease from a year earlier, with the FY2025 full-year figure at -$141.8 million, up 24.05% from the prior year.
• Change in Taxes declined to $41.9 million in Q1 2026 per EW's latest filing, from $57.6 million in the prior quarter.
• Across five years, Change in Taxes topped out at $671.8 million in Q3 2024 and bottomed at -$488.5 million in Q4 2024.
• The 5-year median for Change in Taxes is -$14.4 million (2022), against an average of -$17.5 million.
• Across the five-year window, Change in Taxes slumped 805.17% in 2022 and surged 792.16% in 2024, its largest moves.
• Year by year, Change in Taxes stood at -$14.4 million in 2022, then sank by 678.47% to -$112.1 million in 2023, then tumbled by 335.77% to -$488.5 million in 2024, then surged by 111.79% to $57.6 million in 2025, then decreased by 27.26% to $41.9 million in 2026.
• Per Business Quant, the three latest EW Change in Taxes figures stand at $41.9 million (Q1 2026), $57.6 million (Q4 2025), and -$10.2 million (Q3 2025).